log-BNP

Biomarker1 paper1 finding

  • Humans1

Interventions

1

SGLT2 inhibitors

downin humans1Very low certainty

1 study
  1. SGLT2 inhibitors decrease log-BNP in humans (p = 0.007).

    Humanspulmonary arterial hypertensionn = 83

    Repurposing SGLT2 inhibitors in pulmonary arterial hypertension: A multi-center longitudinal pilot study demonstrating favorable effects on risk profile and ventricular coupling · Therapeutic advances in respiratory disease · 2 Sep 2026

SGLT2 inhibitors →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01